Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
Clinical trial NCT04113109 · COMPLETED
Trial details
- NCT number
- NCT04113109
- Sponsor
- Vanderbilt University Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2025-04-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.